From: Effectiveness and relevant factors of 2 % rebamipide ophthalmic suspension treatment in dry eye
a) Independent variables for the changes of dry eye related symptom scores | ||||||
---|---|---|---|---|---|---|
The changes of dry eye related symptom scores from baseline to 12 weeks | ||||||
Crude | Multivariate | |||||
Unstandardized regression coefficient | Correlation coefficient(r) | P value | Unstandardized regression coefficient | Correlation coefficient(r) | P value | |
Age | −0.06 | −0.092 | 0.67 | |||
Gender (male) | 4.71 | 0.24 | 0.25 | |||
Sjogren syndrome | −1.37 | −0.097 | 0.65 | |||
The presence of previous treatment | −5.71 | −0.45 | 0.029 | |||
Dry eye symptom score | −0.44 | −0.47 | 0.021 | |||
Schirmer’s test | 0.048 | 0.39 | 0.30 | |||
Fluorescein ocular surface staining score | −1.26 | −0.45 | 0.028 | |||
Fluorescein corneal staining score | −1.81 | −0.12 | 0.25 | |||
Fluorescein conjunctiva staining score | −1.81 | −0.48 | 0.017 | −1.81 | −0.48 | 0.017* |
TBUT | −0.7955 | −0.1192 | 0.5791 | |||
The presence of auto-immune disease | −0.589 | −0.045 | 0.83 | |||
b) Independent variables for the changes of fluorescein ocular surface staining score | ||||||
The changes of fluorescein ocular surface staining score from baseline to 12 weeks | ||||||
Crude | Multivariate | |||||
Unstandardized regression coefficient | Correlation coefficient(r) | P value | Unstandardized regression coefficient | Correlation coefficient(r) | P value | |
Age | −0.019 | −0.14 | 0.51 | |||
gender (male) | −0.38 | −0.095 | 0.66 | |||
Sjogren syndrome | −0.20 | −0.069 | 0.75 | |||
The presence of previous treatment | −0.84 | −0.32 | 0.13 | |||
Dry eye symptom score | −0.10 | −0.52 | 0.0097 | −0.10 | −0.52 | 0.0097* |
Schirmer’s test | 0.048 | 0.22 | 0.32 | |||
Fluorescein ocular surface staining score | −0.22 | −0.38 | 0.070 | |||
Fluorescein corneal staining score | −0.39 | −0.25 | 0.23 | |||
Fluorescein conjunctiva staining score | −0.29 | −0.37 | 0.076 | |||
TBUT | −0.036 | −0.029 | 0.89 | |||
The presence of auto-immune disease | 0.17 | 0.064 | 0.77 |